Related Experiment Video

Updated: Jul 12, 2026

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

Could AIDS treatments slip through patents loophole?

P Smaglik

    Nature
    |April 4, 2000
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Engineering Antiviral Agents via Surface Plasmon Resonance13:00

    Engineering Antiviral Agents via Surface Plasmon Resonance

    Published on: June 14, 2022

    Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants09:20

    Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

    Published on: October 18, 2022

    Related Concept Videos

    Antiviral Nucleoside Inhibitors01:22

    Antiviral Nucleoside Inhibitors

    Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...